Back to Posters

BRCA1/2 testing criteria offer high clinical sensitivity for ATM, PALB2 and CHEK2 carriers in a multigene panel cohort

Session:
#108
Date:
Friday, Apr 13, 2018 10:30am – 12:00pm
Conference:
ACMG 2018
Authors:
Ashley Deckman, Carrie Horton, Holly Laduca, Lily Hoang
  • NCCN BRCA1/2 testing criteria demonstrated high clinical sensitivity when applied to ATM, CHEK2, and PALB2.  
  • Individuals with mutations in ATM, CHEK2, and PALB2 were best captured by criteria without an age limit.
  • Further investigation of BRCA2, ATM, CHEK2, and PALB2 mutation carriers not meeting any BRCA1/2 testing criteria will help identify further opportunities to improve sensitivity for without significantly compromising specificity
Abstract Poster